Dr. Shira Knafo discovered a small protein, which inhibits the processes normally associated with impairment, including depression and Alzheimer’s disease, and Israel’s Vigor Medical Technologies won the Innovex Disrupt contest at Tel Aviv’s Innovex 2016 conference.

Israel’s Teva is partnering with Japan’s Heptares to develop a treatment for migraines, and researchers at Ben Gurion University have discovered that sufferers of diabetic foot ulcers frequently also have substantially impaired cognitive function.